$ARMO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARMO BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARMO BioSciences, Inc.. Get notifications about new insider transactions in ARMO BioSciences, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Xu Stella | Director | Option Exercise | D | 39.97 | 18,000 | 719,460 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Xu Stella | Director | Sell | U | 50.00 | 404,900 | 20,245,000 | 0 | 404.9 K to 0 (-100.00 %) |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Xu Stella | Director | Option Exercise | D | 39.97 | 18,000 | 719,460 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Xu Stella | Director | Sell | U | 50.00 | 404,900 | 20,245,000 | 0 | 404.9 K to 0 (-100.00 %) |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Leveque Joseph | Chief Medical Offic ... | Option Exercise | D | 6.97 | 288,789 | 2,012,802 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | VAN VLASSELAER PETER | President and CEO | Option Exercise | D | 6.97 | 216,168 | 1,506,648 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | VAN VLASSELAER PETER | President and CEO | Option Exercise | D | 3.30 | 398,206 | 1,312,686 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | VAN VLASSELAER PETER | President and CEO | Option Exercise | D | 1.32 | 220,513 | 290,768 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | VAN VLASSELAER PETER | President and CEO | Option Exercise | D | 1.32 | 190,641 | 251,379 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | VAN VLASSELAER PETER | President and CEO | Sell | U | 50.00 | 809,865 | 40,493,250 | 0 | 809.9 K to 0 (-100.00 %) |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Sell | U | 50.00 | 409,547 | 20,477,350 | 409,547 | 819.1 K to 409.5 K (-50.00 %) |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Sell | U | 50.00 | 3,709,356 | 185,467,800 | 3,709,356 | 7.4 M to 3.7 M (-50.00 %) |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Legault Pierre | Director | Option Exercise | D | 6.73 | 55,765 | 375,538 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Legault Pierre | Director | Option Exercise | D | 39.97 | 18,000 | 719,460 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Rizvi Naiyer | Director | Option Exercise | D | 6.73 | 19,146 | 128,935 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Rizvi Naiyer | Director | Option Exercise | D | 39.97 | 18,000 | 719,460 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Sell | U | 50.00 | 4,266,683 | 213,334,150 | 0 | 4.3 M to 0 (-100.00 %) |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | CROSS HERB | Chief Financial Off ... | Option Exercise | D | 6.97 | 240,658 | 1,677,338 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Cui Xiangmin | Director | Option Exercise | D | 39.97 | 18,000 | 719,460 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Cui Xiangmin | Director | Sell | U | 50.00 | 1,214,700 | 60,735,000 | 0 | 1.2 M to 0 (-100.00 %) |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | SEIDENBERG BETH C | Director | Option Exercise | D | 39.97 | 18,000 | 719,460 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | SEIDENBERG BETH C | Director | Sell | U | 50.00 | 4,266,683 | 213,334,150 | 0 | 4.3 M to 0 (-100.00 %) |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | D | 39.97 | 18,000 | 719,460 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Sell | U | 50.00 | 409,547 | 20,477,350 | 0 | 409.5 K to 0 (-100.00 %) |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Sell | U | 50.00 | 3,709,356 | 185,467,800 | 0 | 3.7 M to 0 (-100.00 %) |
Mar 28 2018 | ARMO | ARMO BioSciences, ... | Xu Stella | Director | Option Exercise | A | 39.97 | 18,000 | 719,460 | 18,000 | |
Mar 28 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | A | 39.97 | 18,000 | 719,460 | 18,000 | |
Mar 28 2018 | ARMO | ARMO BioSciences, ... | Legault Pierre | Director | Option Exercise | A | 39.97 | 18,000 | 719,460 | 18,000 | |
Mar 28 2018 | ARMO | ARMO BioSciences, ... | Rizvi Naiyer | Director | Option Exercise | A | 39.97 | 18,000 | 719,460 | 18,000 | |
Mar 28 2018 | ARMO | ARMO BioSciences, ... | SEIDENBERG BETH C | Director | Option Exercise | A | 39.97 | 18,000 | 719,460 | 18,000 | |
Mar 28 2018 | ARMO | ARMO BioSciences, ... | Cui Xiangmin | Director | Option Exercise | A | 39.97 | 18,000 | 719,460 | 18,000 | |
Feb 01 2018 | ARMO | ARMO BioSciences, ... | SC China Venture VI Management ... | 10% Owner | Option Exercise | C | 0.00 | 809,800 | 0 | 0 | |
Feb 01 2018 | ARMO | ARMO BioSciences, ... | SC China Venture VI Management ... | 10% Owner | Buy | C | 0.00 | 809,800 | 0 | 809,800 | 0 to 809.8 K |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Option Exercise | C | 0.00 | 446 | 0 | 0 | ||
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Option Exercise | C | 0.00 | 183,351 | 0 | 0 | ||
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Option Exercise | C | 0.00 | 551 | 0 | 0 | ||
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Option Exercise | C | 0.00 | 226,543 | 0 | 0 | ||
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Option Exercise | C | 0.00 | 489 | 0 | 0 | ||
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Option Exercise | C | 0.00 | 200,786 | 0 | 0 | ||
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Option Exercise | C | 0.00 | 1,772 | 0 | 0 | ||
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Option Exercise | C | 0.00 | 728,080 | 0 | 0 | ||
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Option Exercise | C | 0.00 | 2,580 | 0 | 0 | ||
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Option Exercise | C | 0.00 | 1,059,148 | 0 | 0 | ||
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Buy | C | 0.00 | 446 | 0 | 5,838 | 5.4 K to 5.8 K (+8.27 %) | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Buy | C | 0.00 | 183,351 | 0 | 2,397,908 | 2.2 M to 2.4 M (+8.28 %) | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Buy | C | 0.00 | 551 | 0 | 5,392 | 4.8 K to 5.4 K (+11.38 %) | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Buy | C | 0.00 | 226,543 | 0 | 2,214,557 | 2 M to 2.2 M (+11.40 %) | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Buy | C | 0.00 | 489 | 0 | 4,841 | 4.4 K to 4.8 K (+11.24 %) | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Buy | C | 0.00 | 200,786 | 0 | 1,988,014 | 1.8 M to 2 M (+11.23 %) | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Buy | C | 0.00 | 1,772 | 0 | 4,352 | 2.6 K to 4.4 K (+68.68 %) | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Buy | C | 0.00 | 728,080 | 0 | 1,787,228 | 1.1 M to 1.8 M (+68.74 %) | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Buy | C | 0.00 | 2,580 | 0 | 2,580 | 0 to 2.6 K | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | DAG Ventures Management V, LLC | Buy | C | 0.00 | 1,059,148 | 0 | 1,059,148 | 0 to 1.1 M | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 31,315 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 45,961 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 332,271 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 283,627 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 415,869 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,226,156 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,783,704 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 409,547 | 0 | 409,547 | 0 to 409.5 K |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 3,709,356 | 0 | 3,709,356 | 0 to 3.7 M |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 31,315 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 45,961 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 332,271 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 283,627 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 415,869 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,226,156 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,783,704 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Buy | C | 0.00 | 409,547 | 0 | 409,547 | 0 to 409.5 K |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GORDON CARL L | Director | Buy | C | 0.00 | 3,709,356 | 0 | 3,709,356 | 0 to 3.7 M |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 326,242 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 403,097 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 355,429 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 1,296,248 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 1,212,494 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | SEIDENBERG BETH C | Director | Option Exercise | C | 0.00 | 673,173 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | SEIDENBERG BETH C | Director | Buy | C | 0.00 | 4,266,683 | 0 | 4,266,683 | 0 to 4.3 M |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GV 2014 GP, L.L.C. | 10% Owner | Option Exercise | C | 0.00 | 607,350 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GV 2014 GP, L.L.C. | 10% Owner | Buy | C | 0.00 | 607,350 | 0 | 607,350 | 0 to 607.4 K |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Xu Stella | Director | Option Exercise | C | 0.00 | 404,900 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Xu Stella | Director | Buy | C | 0.00 | 404,900 | 0 | 404,900 | 0 to 404.9 K |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Cui Xiangmin | Director | Option Exercise | C | 0.00 | 1,214,700 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Cui Xiangmin | Director | Buy | C | 0.00 | 1,214,700 | 0 | 1,214,700 | 0 to 1.2 M |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 326,242 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 403,097 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 355,429 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 1,296,248 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 1,212,494 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Option Exercise | C | 0.00 | 673,173 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | Kleiner Perkins Caufield & Bye ... | 10% Owner | Buy | C | 0.00 | 4,266,683 | 0 | 4,266,683 | 0 to 4.3 M |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GV 2016 GP, L.L.C. | 10% Owner | Option Exercise | C | 0.00 | 607,350 | 0 | 0 | |
Jan 30 2018 | ARMO | ARMO BioSciences, ... | GV 2016 GP, L.L.C. | 10% Owner | Buy | C | 0.00 | 607,350 | 0 | 607,350 | 0 to 607.4 K |
Page: 1